Non-Animal Cell Line Selection via Recombinant Protein Labels
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for selecting high-producing cell lines in biopharmaceutical production are labor-intensive, resource-consuming, and often expose cells to adventitious agents due to the use of animal-derived components in cell culture media and reagents, leading to contamination risks and reduced protein yields.
Innovation Solution
A method using non-animal derived labels like recombinant Protein A, Protein G, or Protein L for direct staining of cells expressing polypeptides, combined with novel gating strategies based on forward scatter characteristics, to identify and isolate high-producing cell clones without animal-derived components, enabling faster and safer cell line selection.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If animal derived components are used in cell culture media and reagents for cell line selection, then cell growth and protein expression are supported, but cells are exposed to adventitious agents leading to contamination risks
Solution Approach 1:
The invention extracts and removes animal derived components from the cell culture system by using recombinant Protein A, Protein G, or Protein L labels instead of animal derived antibodies or serum. This extraction eliminates the source of adventitious agents while maintaining the functional capability to detect and select high producing cell lines through polypeptide binding.
Solution Approach 2:
The invention introduces recombinant Protein A, Protein G, or Protein L as intermediary binding agents that mediate between the detection system and the polypeptide target. These intermediaries provide the necessary binding function without introducing animal derived components, thus protecting cells from adventitious agent exposure while enabling effective cell line selection.
2Measurement precision
If traditional screening methods are used to identify high producing cell clones, then thorough selection is achieved, but the process is labor-intensive and resource-consuming
Solution Approach 1:
The invention replaces manual, labor-intensive screening methods with a flow cytometry-based detection system using fluorescently labeled recombinant Protein A, Protein G, or Protein L. This substitution automates the selection process, enabling rapid identification of high producing cell lines through quantitative fluorescence measurement while maintaining accurate selection criteria.
Solution Approach 2:
The invention utilizes color changes (fluorescence emission) as an indicator of polypeptide expression levels on cell surfaces. By incorporating fluorescent labels on recombinant Protein A, Protein G, or Protein L that bind to the target polypeptide, the system converts biochemical information into optical signals that can be rapidly detected and quantified by flow cytometry, dramatically improving selection efficiency.
3Measurement precision
If fluorescent markers are over expressed in cells for selection purposes, then marker detection is enhanced, but the desired protein product yield is reduced due to competition for host cell resources
Solution Approach 1:
The invention uses recombinant Protein A, Protein G, or Protein L as external intermediary binding agents that attach to the polypeptide product already present on the cell surface. This approach eliminates the need to over-express fluorescent marker proteins within the host cells, as the external recombinant proteins provide the necessary detection function without competing for host cell transcriptional and translational resources.
Solution Approach 2:
Instead of modifying the host cell to over-express fluorescent markers (internal approach), the invention inverts the approach by using externally applied recombinant Protein A, Protein G, or Protein L conjugated with fluorescent labels. This external labeling strategy achieves the same detection purpose without imposing metabolic burden on the host cells, thereby preserving protein product yield.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach allows for the rapid identification of high-producing cell lines from early stages of development, reducing the need to screen numerous clones and minimizing exposure to adventitious agents, thereby enhancing the efficiency and safety of biopharmaceutical production.
Implementation Method 1
contacting the cell population with a label which binds to said polypeptide on the surface of the cell
Implementation Method 2
detecting the binding of said label to the polypeptide on the surface of said cell
Implementation Method 3
detecting the binding of said label to the polypeptide on the surface of said cell
Implementation Method 4
novel gating strategies based on the forward scatter (FSC) properties of the cells
Data Source
AI summary
The invention provides methods for the rapid identification and selection of cell lines suitable for biopharmaceuticals production, which do no utilize animal derived components.